From: Overview on the complexity of androgen receptor-targeted therapy for prostate cancer
Agent | Targets | Reference |
---|---|---|
Urolithins (Walnut polyphenol metabolites) | PSA ↓ | Sánchez-González et al. [24] |
Bcl-2 ↓ | ||
AR inhibition | ||
Curcumin | AR inhibition | Zhou et al. [25] |
Imidazopyridine | PI3K/Akt ↓ | Muniyan et al. [26] |
AR induced signaling ↓ | ||
Atraric acid | Inhibition of intramolecular amino/carboxy (N/C)-terminal interaction of the AR | Hessenkemper et al. [27] |
Furanoditerpenoid spongia-13(16),-14-dien-19- oic acid | Yang et al. [28] | |
AZD3514 | AR ↓ | Loddick et al. [31] |
Rosmarinus officinalis extract | AR ↓ | Petiwala et al. [29] |
Betulinic acid | AR ↓ | Reiner et al. [30] |
Isochaihulactone | AR mRNA ↓ | |
Shikonin | AR protein ↓ | Jang et al. [32] |